Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 98.52M CNY in the quarter ending March 31, 2026, a decrease of -3.15%. This brings the company's revenue in the last twelve months to 459.57M, up 2.62% year-over-year. In the year 2025, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 462.78M, down -4.38%.

• Revenue (ttm): 459.57M
• Revenue Growth: +2.62%
• P/S Ratio: 4.98
• Revenue / Employee: 402.43K
• Employees: 1,142
• Market Cap: 2.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	462.78M	-21.18M	-4.38%
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error